F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Vaccine

Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.

Guillain-Barré and Vaccines: What You Need to Know

The link between the rare neurological disorder and the Johnson & Johnson Covid-19 vaccine may be real, but the risk appears to be very small.

Síndrome Guillain-Barré: qué es y cómo se relaciona con las vacunas

La relación entre este raro trastorno neurológico y la vacuna contra la COVID-19 de Johnson & Johnson puede ser real, pero el riesgo parece ser muy pequeño.